Dan Gabriel Duda, Ph.D., D.M.D.
Co-Author
This page shows the publications co-authored by Dan Duda and David Ziehr.
Connection Strength
0.405
-
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients. Oncologist. 2021 Aug; 26(8):e1483.
Score: 0.234
-
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients. Oncologist. 2017 01; 22(1):25-32.
Score: 0.171
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.